Identification of p53 genetic suppressor elements which confer resistance to cisplatin

Oncogene

Volumn 14, Issue 2, 1997, Pages 185-193

  Gallagher, W M ^a   Cairney, M ^a   Schott, B ^b   Roninson, I B ^b   Brown, R ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Cisplatin; P53; Resistance

Indexed keywords

CISPLATIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA LIBRARY; DRUG RESISTANCE; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEIC ACID PROBE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTISENSE ELEMENTS (GENETICS); CISPLATIN; DNA DAMAGE; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, P53; HUMANS; MICE; OVARIAN NEOPLASMS; RETROVIRIDAE; SERINE ENDOPEPTIDASES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE;

EID: 0031014097     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1200813     Document Type: Article

References (49)

1. Anderson ME and Tegtmeyer P. (1995). BioEssays, 17, 3-7.
2. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin ARM and Brown R. (1996). Cancer Res., 56, 1374-1381.
3. Arai N, Nomura D, Yokota K, Wolf D, Brill E, Shohat O and Rotter V. (1986). Mol. Cell. Biol., 6, 3232-3239.
4. Baker SJ, Markowitz S, Fearon ER, Wilson JKV and Vogelstein B. (1990). Science, 249, 912-915.
5. Barton CM and Lemoine NR. (1995). Br. J. Cancer, 71, 429-437.
6. Bates S and Vousden KH. (1996). Curr. Opin. Gen. Dev., 6, 12-19.
7. Bayever E, Haines K, Iversen PL, Ruddon RW, Pirruccello SJ, Mountjoy CP, Arneson MA and Smith L. (1994). Leukemia Lymphoma, 12, 223-231.
8. Bischoff JR, Friedman PN, Marshak DR, Prives C and Beach D. (1990). Proc. Natl. Acad. Sci. USA, 87, 4766-4770.
9. Bishop MR, Iversen PL, Bayever E, Sharp JG, Greiner TC, Copple BL, Ruddon R, Zon G, Spinolo J, Arneson M, Armitage JO and Kessinger A. (1996). J. Clin. Oncol., 14, 1320-1326.
10. Bi S, Lanza F and Goldman J. (1994). Cancer Res., 54, 582-586.
11. Brown R. (1993). Annals of Oncology, 4, 623-629.
12. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B and Kaye SB. (1993). Int. J. Cancer, 55, 678-684.
13. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
14. Coffin JM. (1990). Virology, Fields B and Knipe DM. (ed). Raven: New York, pp. 1437-1500.
15. Deppert W. (1994). Sem. Cancer Biol., 5, 187-202.
16. Denhardt DT. (1992). Annals New York Acad. Sci., 660, 70-76.
17. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. (1992). Nature Genetics, 1, 45-49.
18. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS. (1995). Oncogene, 11, 1217-1228.
19. Fan S, SmithML, Rivet II, DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr., AJ and O'Connor PM. (1995). Cancer Res., 55, 1649-1654.
20. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z. (1993). Cancer Res., 53, 3186-3192.
21. Gudkov AV, Zelnick CR, Kazarov AR, Thimmapaya R, Shuttle DP, Beck WT and Roninson IB. (1993). Proc. Natl. Acad. Sci. USA, 90, 3231-3235.
22. Gudkov AV, Kazarov AR, Thimmapaya R, Axenovich SA, Mazo IA and Roninson IB. (1994). Proc. Natl. Acad. Sci. USA, 91, 3744-3748.
23. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF and Hamilton TC. (1993). Cancer Res., 53, 5225-5232.
24. Hansen S, Hupp TR and Lane DP. (1996). J. Biol. Chem., 271, 3917-3924.
25. Holzmayer TA, Pestov DG and Roninson IB. (1992). Nucleic Acids Res., 20, 711-717.
26. Harris CC. (1996). Br. J. Cancer, 73, 261-269.
27. Herskowitz I. (1987). Nature, 329, 219-222.
28. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell, 71, 875-886.
29. Hupp TR, Sparks A and Lane DP. (1995). Cell, 83, 237-245.
30. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
31. Lowe S. (1995). Curr. Opin. Onco., 7, 547-553.
32. McLaughlin K, Stephens I, McMahon N and Brown R. (1991). Cancer Res., 51, 2242-2245.
33. McIlwrath AJ, Vasey PA, Ross GM and Brown R. (1994). Cancer Res., 54, 3718-3722.
34. Miller AD and Buttimore C. (1986). Mol. Cell. Biol., 6, 2895-2902.
35. Miller AD and Rosman GJ. (1989). Bio Techniques, 7, 980-990.
36. Ossovskaya V, Mazo IA, Strezoska Z, Chernova O, Chernov M, Stark G, Chumakov P and Gudkov AV. Proc. Natl. Acad. Sci. USA, in press.
37. Picksley SM and Lane DP. (1994). Curr. Opin. Cell Biol., 6, 853-858.
38. Plumb JA, Milroy R and Kaye SB. (1989). Cancer Res., 49, 4435-4440.
39. Roninson IB, Gudkov AV, Holzmayer TA, Kirschling DJ, Kazarov AR, Zelnick CR, Mazo IA, Axenovich S and Thimmapaya R. (1995). Cancer Res., 55, 4023-4028.
40. Rosenberg B. (1985). Cancer, 5, 2303-2316.
41. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu S, Oren M and Vousden KH. (1996). EMBO J., 15, 827-838.
42. Sherman SE and Lippard SJ. (1987). Chem. Rev., 87, 1153-1181.
43. Shimamura A and Fisher DE. (1996). Clin. Cancer Res., 2, 435-440.
44. Sorenson CM and Eastman A. (1988). Cancer Res., 48, 4484-4488.
45. Soussi T, de Fromentel CC and May P. (1990). Oncogene, 5, 945-952.
46. Takayama KM and Inouye M. (1990). Crit. Rev. Biochem. Mol. Biol., 25, 155-184.
47. Vasey PA, Jones NA, Jenkins S, Dive C and Brown R. (1996). Mol. Pharmacol., in press.
48. Vogelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
49. Wigler M, Silverstein S, Lee LS, Pellicer A, Cheng YC and Axel R. (1977). Cell, 11, 223-232.